The CRASH-3 trial is a randomised controlled trial that will examine the effect of tranexamic acid (versus placebo) on death and disability in 13,000 patients with traumatic brain injury. However, it is uncertain whether tranexamic acid is effective in traumatic brain injury. Tranexamic acid prevents blood clots from breaking down and reduces bleeding.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |